No Data
No Data
Diageo's Challenges Posed by GLP-1 Weight-Loss Drugs Cited by Fundsmith Manager for Selling Stake
TD Cowen Maintains Hold on Diageo, Raises Price Target to $129
Diageo Analyst Ratings
Why Investors Should Buy Diageo Stock (DEO) on the Dip
Diageo Identifies 2025 Socialising Trends in New Global Report
Diageo Plc (NYSE:DEO): An Undervalued Global Leader in Beverages Manufacturing
No Data